aspirin and thienopyridine

aspirin has been researched along with thienopyridine in 129 studies

Research

Studies (129)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	68 (52.71)	29.6817
2010's	61 (47.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choo, JK; Kereiakes, DJ; Young, JJ	1
Brinkman, WT; Chaikof, EL; Najibi, S; Terramani, TT	1
Anderson, HV; Moustapha, A	1
Feloney, CD; Malacaria, B	1
Curtin, R; Fitzgerald, DJ	1
Berger, PB; Charnoff, NE; Fasseas, P; Horlocker, T; Lennon, RJ; Melby, S; Orford, JL; Wilson, SH	1
Bhatt, DL; Hostetter, JC	1
Tendera, M; Wojakowski, W	1
Behan, MW; Storey, RF	1
Rodgers, JE; Steinhubl, SR	1
Guirguis, LM; Johnson, JA; Klinke, JA; Lee, TK; Lewanczuk, RZ; Majumdar, SR; Toth, EL	1
Kandzari, DE	1
Cattaneo, M	1
Furman, MI; Tamberella, MR	1
Cox, DA; Garcia, E; Griffin, JJ; Grines, CL; Guagliumi, G; Lansky, AJ; Mehran, R; Musumeci, G; Stone, GW; Stuckey, T; Tcheng, JE; Turco, M	1
Berger, P; Grines, C; Harrington, RA; Ohman, EM; Popma, JJ; Weitz, JI	1
Binder, BR; Christ, G; Glogar, D; Gottsauner-Wolf, M; Huber, K; Huber-Beckmann, R; Nikfardjam, M; Wojta, J	1
Ferguson, JJ; Kadakia, RA	1
Ambrosini, V; Bolognese, L; Bongo, AS; Gaglione, A; Galassi, AR; Marzocchi, A; Petronio, AS; Savonitto, S; Tolaro, S	1
Herbert, JM; Savi, P	1
Asai, F; Jakubowski, JA; Niitsu, Y; Sugidachi, A	1
Hackam, DG	1
Andre, P; Conley, PB; Phillips, DR; Sinha, U	1
Alcalde, R; Berg, C; Brizolara, AA; Caramori, P; Gomes, V; Lasevitch, R; Melchior, R; Roman, M	1
Behar, S; Gottlieb, S; Hammerman, H; Hasdai, D; Hod, H; Iakobishvili, Z; Konstantino, Y; Porter, A; Sandach, A; Zahger, D	1
Battler, A; Hasdai, D; Iakobishvili, Z; Konstantino, Y; Porter, A; Shachar, L	1
Freson, K; Thys, C; Van Geet, C; Wittevrongel, C	1
Gurbel, PA; Tantry, US; Wiviott, SD	1
Bliden, KP; Gurbel, PA; Tantry, US	1
Bonow, RO; Casey, DE; Gardner, TJ; Grines, CL; Lockhart, PB; Moliterno, DJ; O'Gara, P; Whitlow, P	4
Steinhubl, SR	1
Hamdalla, H; Steinhubl, SR	1
Fontana, P	1
Airoldi, F; Bonizzoni, E; Briguori, C; Buellesfeld, L; Carlino, M; Chieffo, A; Colombo, A; Cosgrave, J; Gerckens, U; Godino, C; Grube, E; Latib, A; Melzi, G; Michev, I; Montorfano, M; Morici, N; Qasim, A; Sangiorgi, GM	1
Bavry, AA; Bhatt, DL	1
Banares, M; Gollapudi, RR; Lee, SS; Price, MJ; Sawhney, N; Schatz, RA; Teirstein, PS; Valencia, R; Wong, GB	1
Di Pasquale, G; Rubboli, A	1
El-Gazzar, AR; Hafez, HN; Hussein, HA	1
Béraut, E; Boccalon, H; Bura-Rivière, A; Cambou, JP; Guilhem, JM; Labro, S; Séverac, D; Vaysse, N	1
Boden, WE; Hoekstra, J; Miller, CD	1
Francescone, S; Halperin, JL	1
Drouet, L	1
Casterella, PJ; Tcheng, JE	1
Angiolillo, D; Bates, E; Berger, PB; Bhatt, D; Braunwald, E; Cannon, CP; Furman, MI; Gurbel, P; Michelson, AD; Peterson, E; Wiviott, S	1
Bream-Rouwenhorst, HR; Hobbs, RA; Horwitz, PA	1
Nappi, J	1
Baigent, C; Hirsh, J; Patrono, C; Roth, G	1
Anfossi, G; Russo, I; Trovati, M	1
Alexander, KP; Kosiborod, MN; Peterson, ED; Rao, SV; Rumsfeld, JS; Spertus, JA; Wang, TY; Xiao, L	1
Airoldi, F; Bedogni, F; Bonizzoni, E; Brambilla, N; Briguori, C; Carlino, M; Chieffo, A; Colombo, A; Cosgrave, J; Godino, C; Latib, A; Montorfano, M; Morici, N; Sangiorgi, GM	1
Burtt, D; Chodosh, A; Korr, KS	1
Blake, G; Margey, RJ; O'Connell, PR; O'Riordan, JM	1
Eisenberg, MJ; Filion, KB; Libersan, D; Richard, PR	1
Irsara, S; Liessi, G; Marigo, L; Tonello, D; Visonà, A; Zalunardo, B; Zotta, L	1
Cross, J	1
Mathewkutty, S; McGuire, DK	1
Das, K; Das, P; Koshy, SK; Robinson, A	1
Cox, DA; Dangas, GD; Fahy, M; Garcia, E; Griffin, JJ; Grines, CL; Guagliumi, G; Iyengar, S; Lansky, AJ; Mehran, R; Rabbani, LE; Stant, J; Stone, GW; Stuckey, T; Tcheng, JE; Turco, M	1
Harrington, RA; Sellers, MB; Tricoci, P	1
Barnathan, ES; Bordes, P; Braunwald, E; Burton, P; Gibson, CM; Hricak, V; Markov, V; Mega, JL; Misselwitz, F; Mohanavelu, S; Oppenheimer, L; Poulter, R; Witkowski, A	1
Hokimoto, S; Kaikita, K; Matsui, K; Noda, K; Ogawa, H; Oshima, S; Sugiyama, S; Sumida, H	1
Kumar, A; Roberts, DH	1
Chen, KY; Chetcuti, S; Grossman, MP; Gurm, H; Meier, P; Rha, SW; Tamhane, U	1
Lane, DA; Lip, GYH; Tay, KH	1
Avsar, O; Batyraliev, TA; Fettser, DV; Islek, M; Preobrazhenskiĭ, DV; Sidorenko, BA; Vural, A	1
Jennings, DL; Kalus, JS	1
Solomon, S; Vacek, JL	1
Gurbel, PA; Tantry, US	1
Abualsaud, AO; Eisenberg, MJ	1
Ebina, T; Hashiba, K; Hibi, K; Iwahashi, N; Kimura, K; Kosuge, M; Maejima, N; Morita, S; Nakachi, T; Ohtsuka, F; Okuda, J; Sugano, T; Tahara, Y; Tsukahara, K; Umemura, S	1
Islam, AM; Patel, PM	1
Hagiwara, N; Mori, F; Ogawa, H; Takagi, A; Uchida, Y	1
Chew, DP; Prakash, R; Wong, YW	1
Hezard, N; Macchi, L; Tessier-Marteau, A	1
Gurbel, PA; Mahla, E; Metzler, H; Tantry, US	1
Batyraliev, TA; Besnili, F; Fettser, DV; Niiazova-Karben, ZA; Preobrazhenskiĭ, DV; Sidorenko, BA	1
Marcucci, R	1
Cano, O; Castro, JE; Olagüe, J; Osca, J; Salvador, A; Sancho-Tello, MJ	1
Fujita, M; Haruma, K; Honda, K; Ishii, M; Kamada, T; Matsumoto, H; Murao, T; Sakakibara, T; Shiotani, A; Tarumi, K	1
Mantha, S; Pianka, AM; Tsapatsaris, N	1
Caglayan, E; Er, F; Erdmann, E; Gassanov, N	1
Motovska, Z	1
Dangas, GD; Mehran, R; Nikolsky, E; Parise, H; Pocock, SJ; Stone, GW; Xu, K; Yu, J	1
Abe, M; Araki, M; Byrne, RA; Ehara, N; Eizawa, H; Fujiwara, H; Furukawa, Y; Inada, T; Iwabuchi, M; Kaburagi, S; Kadota, K; Kastrati, A; Kimura, T; Kita, T; Mitsudo, K; Mitsuoka, H; Mizoguchi, T; Morimoto, T; Nakagawa, Y; Nakano, A; Natsuaki, M; Nobuyoshi, M; Nohara, R; Shiomi, H; Shizuta, S; Suwa, S; Tada, T; Takizawa, A; Taniguchi, R; Tazaki, J	1
Cho, KI; Jang, JS; Je, HG; Jeong, YH; Jin, HY; Kim, BH; Kim, DI; Kim, DK; Kim, DS; Kim, WJ; Lee, JY; Lee, SW; Park, YH; Seo, JS; Seol, SH; Yang, TH	1
Abtan, J; Aubry, P; Barthélémy, O; Belle, L; Beygui, F; Boueri, Z; Carrié, D; Cayla, G; Collet, JP; Cuisset, T; Elhadad, S; Henry, P; Kerneis, M; Monségu, J; Montalescot, G; Motreff, P; O'Connor, SA; Pouillot, C; Rangé, G; Rousseau, H; Sabouret, P; Saint-Etienne, C; Silvain, J; Van Belle, E; Vicaut, E	1
Claessen, BE; Dangas, GD; Mehran, R; Stone, GW; Xu, K	1
Ikari, Y; Kotani, J; Kyo, E; Nakamura, M; Yokoi, H	1
Bassand, JP; Bhatt, DL; Bode, C; Braunwald, E; Burton, P; Chakrabarti, AK; Cohen, M; Gibson, CM; Goto, S; Mega, J; Mohanavelu, S; Stone, G; Verheugt, FW	1
Becker, RC; Breithardt, G; Califf, RM; Fox, KA; Goodman, SG; Hacke, W; Halperin, JL; Hankey, GJ; Mahaffey, KW; Nessel, CC; Patel, MR; Piccini, JP; Singer, DE; Stevens, SR; White, HD	1
Cutlip, DE; Kereiakes, D; Massaro, J; Matteau, A; Mauri, L; Normand, SL; Orav, EJ; Steg, PG; Yeh, RW	1
Becker, RC; Chen, E; Cornel, JH; Dery, JP; Harrington, RA; Hord, E; Huber, K; Jennings, LK; Judge, HM; Kotha, J; Mahaffey, KW; Moccetti, T; Moliterno, DJ; Rorick, TL; Smyth, SS; Storey, RF; Strony, J; Thomas, GS; Tricoci, P; Valgimigli, M	1
Angiolillo, DJ; Baker, BA; Heiselman, DE; Jakubowski, JA; Li, W; Price, MJ	1
Alexander, KP; Li, S; Magid, DJ; Peterson, ED; Roe, MT; Ting, HH; Wang, TY	1
Abtan, J; Aubry, P; Barthélémy, O; Beygui, F; Carrié, D; Cayla, G; Collet, JP; Cuisset, T; Elhadad, S; Kerneis, M; Lhoest, N; Monségu, J; Montalescot, G; O'Connor, SA; Ohlmann, P; Rangé, G; Rousseau, H; Sabouret, P; Saint-Etienne, C; Schiele, F; Silvain, J; Van Belle, E; Vicaut, E	1
Allocco, DJ; Christen, T; Garratt, KN; Jenkins, RG; Kereiakes, DJ; Lee, DP; Mauri, L; Pow, TK; Weaver, WD; Winters, KJ	1
Cho, JY; Choi, RK; Hong, SJ; Joo, HJ; Kang, DO; Kim, HD; Kim, JS; Lee, HJ; Lim, DS; Park, JH; Park, JS; Yu, CW	1
Cutlip, DE; Darius, H; Driscoll-Shempp, P; Garratt, KN; Gershlick, AH; Iancu, AC; Kandzari, DE; Kereiakes, DJ; Lee, DP; Massaro, JM; Mauri, L; Meredith, IT; Ormiston, J; Simon, DI; Steg, PG; Tanguay, JF; Trebacz, J; Windecker, S; Yeh, RW	1
Cohen, DJ; Cutlip, DE; Gershlick, AH; Iancu, AC; Jacobs, A; Kereiakes, DJ; Massaro, JM; Mauri, L; Rinaldi, MJ; Steg, PG; Tanguay, JF; Windecker, S; Wiviott, SD; Yeh, RW	1
Chang, L; Yeh, RW	1
Gerson, LB; Shalman, D	1
Braunwald, E; Cohen, DJ; Cutlip, DE; D'Agostino, RB; Elmariah, S; Kereiakes, DJ; Massaro, JM; Mauri, L; Steg, PG; Windecker, S; Wiviott, SD; Yeh, RW	1
Cohen, DJ; Cutlip, DE; Hermiller, JB; Hsieh, WH; Kereiakes, DJ; Krucoff, MW; Massaro, JM; Mauri, L; Steg, PG; Windecker, S; Yeh, RW	1
Ansell, J; Chang, P; Fonarow, GC; Gersh, BJ; Go, AS; Hylek, EM; Kowey, P; Lopes, RD; Mahaffey, KW; Peterson, ED; Piccini, JP; Rao, M; Simon, DN; Singer, DE; Thomas, L	1
Mospan, CM	1
Ebina, T; Hibi, K; Imoto, K; Karube, N; Kimura, K; Nagashima, Z; Tsukahara, K; Uchida, K; Umemura, S	1
Brindis, RG; Cutlip, DE; Garratt, KN; Holmes, DR; Hsieh, WH; Kereiakes, DJ; Lee, DP; Massaro, JM; Mauri, L; Meredith, IT; Steg, PG; Tanguay, JF; Trebacz, J; Weaver, WD; Yeh, RW	1
Apruzzese, PK; Camenzind, E; Cohen, DJ; Cutlip, DE; Gershlick, AH; Kereiakes, DJ; Massaro, JM; Mauri, L; Normand, SL; Rinaldi, MJ; Secemsky, EA; Song, Y; Spertus, JA; Steg, PG; Wijns, W; Yeh, RW	1
Cutlip, DE; Kereiakes, DJ; Massaro, JM; Mauri, L; Steg, PG; Wiviott, SD; Yeh, RW	1
Ako, J; Hashimoto, T	1
Arnold, SV; Bhatt, DL; Chhatriwalla, AK; Cohen, DJ; Gosch, K; Graham, G; Grodzinsky, A; Jones, PG; Kosiborod, M; Lind, M; McGuire, DK; Sharma, P; Spertus, JA; Steg, PG; Wang, TY	1
Apruzzese, PK; Cannon, CP; Cohen, DJ; Cutlip, DE; D'Agostino, RB; Kereiakes, DJ; Massaro, JM; Mauri, L; Secemsky, EA; Steg, PG; Yeh, RW	1
Aoki, T; Harada, K; Hirayama, K; Ishii, H; Kawamiya, T; Kawashima, K; Kunimura, A; Murohara, T; Negishi, Y; Shibata, Y; Sumi, T; Suzuki, S; Tatami, Y; Yamamoto, D	1
Amano, H; Fuku, Y; Goto, T; Habara, S; Kadota, K; Kubo, S; Otsuru, S; Tada, T; Tanaka, H	1
Benfatto, G; Drago, F; Gozzo, L; Longo, L; Mansueto, S; Navarria, A; Pani, L; Salomone, S; Sottosanti, L	1
Nigam, N; Patel, P; Sengupta, N	1
Choi, JM; Chung, H; Han, SJ; Jung, HC; Kim, J; Kim, JL; Kim, SG; Lim, JH; Oh, S; Park, JY; Yang, HJ	1
Ako, J; Ando, K; Anzai, H; Fujii, K; Hamasaki, T; Iijima, R; Inoue, K; Inoue, T; Ishiwata, S; Ito, Y; Kadotani, M; Kataoka, T; Kawaguchi, K; Kawata, M; Kinutani, H; Kuroda, K; Morita, T; Nakamura, M; Niinuma, H; Nishida, Y; Ochiai, M; Ohira, H; Okada, H; Omiya, K; Otake, H; Shinke, T; Takiuchi, S; Tanaka, H; Ueda, Y; Urasawa, K; Yasaka, Y; Yokoi, H; Yoshiyama, M; Zen, K	1
Al Mamary, A; Campello, E; Dalla Valle, F; Maggiolo, S; Napodano, M; Piazza, D; Simioni, P; Spiezia, L	1
Hou, MC; Hu, HY; Lin, CC; Lin, XH; Luo, JC; Luo, PJ; Ting, PH	1
Fujimoto, K; Fujishiro, M; Haruma, K; Horimatsu, T; Hoteya, S; Iwakiri, R; Kaminishi, M; Katada, C; Kato, M; Kida, M; Kobayashi, K; Kodashima, S; Koike, K; Kutsumi, H; Matsuda, K; Matsuda, T; Miyata, H; Muto, M; Niikura, R; Oda, I; Ohtsuka, K; Ryozawa, S; Saito, Y; Shinozaki, T; Tajiri, H; Tanaka, K; Uemura, N; Yamada, A; Yamamoto, H	1
Alexander, JH; Goodman, SG; Hagström, E; Harrington, RA; Lopes, RD; Neely, ML; Sharma, A; Wallentin, L; Wojdyla, DM	1
Chatila, A; Guturu, P; Krill, TS; Marcondes, F; Parupudi, S; Samuel, R	1
Aijaz, S; Akhter, Z; Malik, R; Pathan, A; Rind, IA; Sattar, S	1
Cutlip, DE; Hsieh, WH; Kereiakes, DJ; Massaro, JM; Mauri, L; Stefanescu Schmidt, AC; Steg, PG; Tanguay, JF; Yeh, RW	1

Reviews

50 review(s) available for aspirin and thienopyridine

Article	Year
A guide to drug use during percutaneous coronary intervention. Drugs, 2002, Volume: 62, Issue:18 Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clinical Trials as Topic; Coronary Thrombosis; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Intraoperative Period; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Thrombin	2002
Platelets: is aspirin sufficient or must we know how to pronounce abciximab? Seminars in vascular surgery, 2002, Volume: 15, Issue:4 Topics: Abciximab; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Blood Platelets; Clopidogrel; Endarterectomy, Carotid; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Ticlopidine; Tirofiban; Tyrosine	2002
Contemporary view of the acute coronary syndromes. The Journal of invasive cardiology, 2003, Volume: 15, Issue:2 Topics: Acute Disease; Angina, Unstable; Anticoagulants; Aspirin; Clinical Trials as Topic; Coronary Disease; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Syndrome	2003
Pharmacogenetics of antiplatelet drugs. TheScientificWorldJournal, 2002, Mar-22, Volume: 2 Topics: Animals; Aspirin; Dipyridamole; Humans; Pharmacogenetics; Pyridines	2002
The expanding role of antiplatelet agents in coronary artery disease. A current review of aspirin, glycoprotein IIb/IIIa inhibitors, and the thienopyridines. Minerva cardioangiologica, 2003, Volume: 51, Issue:5 Topics: Aspirin; Coronary Artery Disease; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines	2003
Role of antiplatelet drugs in the prevention of cardiovascular events. Thrombosis research, 2003, Jun-15, Volume: 110, Issue:5-6 Topics: Aspirin; Benzamidines; Clopidogrel; Coronary Artery Disease; Humans; Myocardial Infarction; Oximes; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Stroke; Ticlopidine; Treatment Outcome	2003
Antiplatelet therapy in cardiovascular disease. Postgraduate medical journal, 2004, Volume: 80, Issue:941 Topics: Aspirin; Cardiovascular Diseases; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines	2004
Clopidogrel's role in the management of atherosclerotic disease: a focus on acute coronary syndromes. Expert review of cardiovascular therapy, 2003, Volume: 1, Issue:4 Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Clopidogrel; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyridines; Stents; Ticlopidine; Treatment Outcome; Vascular Diseases	2003
Current concepts in the antithrombotic management of non-ST-elevation acute coronary syndromes. Current cardiology reports, 2004, Volume: 6, Issue:4 Topics: Angina, Unstable; Aspirin; Clinical Trials as Topic; Coronary Artery Disease; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Thrombolytic Therapy	2004
Antiplatelet agents. The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5 Suppl 3 Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Drug Design; Drug Resistance; Drug Therapy, Combination; Humans; Meta-Analysis as Topic; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Ticlopidine	2004
The role of platelet inhibition in the drug-eluting stent era. Coronary artery disease, 2004, Volume: 15, Issue:6 Topics: Aspirin; Coronary Stenosis; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Stents	2004
Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, Volume: 126, Issue:3 Suppl Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Clopidogrel; Contraindications; Coronary Restenosis; Coronary Stenosis; Drug Therapy, Combination; Evidence-Based Medicine; Fibrinolytic Agents; Heparin; Hirudins; Humans; Immunoglobulin Fab Fragments; Peptide Fragments; Practice Guidelines as Topic; Pyridines; Recombinant Proteins; Risk Assessment; Stents; Ticlopidine	2004
Optimal antithrombotic treatment for percutaneous coronary intervention. Minerva cardioangiologica, 2005, Volume: 53, Issue:1 Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Blood Coagulation; Clinical Trials as Topic; Clopidogrel; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Stents; Thrombin; Thrombosis; Ticlopidine; Treatment Outcome	2005
Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. Seminars in thrombosis and hemostasis, 2005, Volume: 31, Issue:2 Topics: Adenosine Diphosphate; Animals; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Clopidogrel; Cohort Studies; Double-Blind Method; Drug Resistance; Fibrinolytic Agents; Forecasting; Humans; Membrane Proteins; Meta-Analysis as Topic; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Pyridines; Randomized Controlled Trials as Topic; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombophilia; Thrombosis; Ticlopidine	2005
Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity. Seminars in thrombosis and hemostasis, 2005, Volume: 31, Issue:2 Topics: Adenosine Diphosphate; Adult; Animals; Aspirin; Biotransformation; Clinical Trials, Phase I as Topic; Clopidogrel; Collagen; Drug Evaluation, Preclinical; Drug Synergism; Fibrinolytic Agents; Hemostasis; Humans; Male; Membrane Proteins; Molecular Structure; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prodrugs; Purinergic P2 Receptor Antagonists; Pyridines; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thiophenes; Thrombin; Thrombosis; Ticlopidine	2005
Cardiovascular risk prevention in peripheral artery disease. Journal of vascular surgery, 2005, Volume: 41, Issue:6 Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Peripheral Vascular Diseases; Pyridines; Risk Factors	2005
Therapeutic approaches in arterial thrombosis. Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:8 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atherosclerosis; Blood Platelets; Clopidogrel; Coronary Thrombosis; Disease Models, Animal; Disease Progression; Fibrinolytic Agents; Humans; Mice; Models, Biological; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Risk; Signal Transduction; Thrombosis; Ticlopidine; Time Factors	2005
Mechanisms of action and targets for actual and future antiplatelet drugs. Mini reviews in medicinal chemistry, 2006, Volume: 6, Issue:6 Topics: Aspirin; Cyclooxygenase Inhibitors; Drug Design; Humans; Platelet Aggregation Inhibitors; Platelet Membrane Glycoprotein IIb; Purinergic Antagonists; Pyridines	2006
Clinical applications of antiplatelet therapy. Reviews in cardiovascular medicine, 2006,Summer, Volume: 7, Issue:3 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Cyclooxygenase Inhibitors; Drug Resistance; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Pyridines; Ticlopidine	2006
Prasugrel. Expert opinion on investigational drugs, 2006, Volume: 15, Issue:12 Topics: Adenosine Diphosphate; Animals; Aspirin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; Clopidogrel; Collagen; Coronary Disease; Drug Evaluation, Preclinical; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Drugs, Investigational; Humans; Piperazines; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prodrugs; Purinergic P2 Receptor Antagonists; Pyridines; Rats; Receptors, Purinergic P2Y12; Thiophenes; Ticlopidine	2006
Optimizing antiplatelet therapy for the ACS patient: reacting to clinical trial data from the ISAR-REACT-2 studies. Reviews in cardiovascular medicine, 2006, Volume: 7 Suppl 4 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Biomarkers; Blood Platelets; Combined Modality Therapy; Drug Therapy, Combination; Humans; Myocardial Infarction; Patient Selection; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome; Troponin; Up-Regulation	2006
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Feb-15, Volume: 69, Issue:3 Topics: Advisory Committees; Aspirin; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Thrombosis; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Pyridines; Stents; Time Factors; United States	2007
Oral antiplatelet therapy for percutaneous coronary revascularization. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Apr-01, Volume: 69, Issue:5 Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Disease; Coronary Thrombosis; Dose-Response Relationship, Drug; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Ticlopidine	2007
[Update on antithrombotic treatments in arterial diseases]. Revue medicale suisse, 2007, Feb-07, Volume: 3, Issue:97 Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Pyridines; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine	2007
Triple therapy of warfarin, aspirin and a thienopyridine for patients treated with vitamin K antagonists undergoing coronary stenting. A review of the evidence. Internal and emergency medicine, 2007, Volume: 2, Issue:3 Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Pyridines; Stents; Vitamin K; Warfarin	2007
ST-elevation myocardial infarction: the role of adjunctive antiplatelet therapy. The American journal of emergency medicine, 2008, Volume: 26, Issue:2 Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Clopidogrel; Electrocardiography; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Ticlopidine; Tirofiban; Tyrosine	2008
Review of the 2005 American College of Cardiology, American Heart Association, and Society for Cardiovascular Interventions guidelines for adjunctive pharmacologic therapy during percutaneous coronary interventions: practical implications, new clinical da American heart journal, 2008, Volume: 155, Issue:5 Topics: American Heart Association; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Disease; Drug-Eluting Stents; Hirudins; Humans; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Pyridines; Recombinant Proteins; Societies, Medical; Thrombolytic Therapy; Ticlopidine; United States	2008
The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention. Clinical cardiology, 2008, Volume: 31, Issue:3 Suppl 1 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Thrombosis	2008
Resistance to aspirin and thienopyridines in diabetes mellitus and metabolic syndrome. Current vascular pharmacology, 2008, Volume: 6, Issue:4 Topics: Aspirin; Cardiovascular Diseases; Diabetes Mellitus; Drug Resistance; Humans; Metabolic Syndrome; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Risk Factors	2008
Antiplatelet agents in the perioperative period. Archives of surgery (Chicago, Ill. : 1960), 2009, Volume: 144, Issue:1 Topics: Algorithms; Aspirin; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Risk Factors	2009
Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation, 2009, Mar-31, Volume: 119, Issue:12 Topics: Aged; Aspirin; Case-Control Studies; Data Collection; Drug-Eluting Stents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; MEDLINE; Middle Aged; Platelet Aggregation Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Thrombosis	2009
Antithrombotic treatment before and after peripheral artery percutaneous angioplasty. Blood transfusion = Trasfusione del sangue, 2009, Volume: 7, Issue:1 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Coronary Restenosis; Dipyridamole; Drug Combinations; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Thrombolytic Therapy	2009
Antiplatelet therapy for improving post-PCI outcomes: interpreting current treatment guidelines for optimal management of the post-ACS patient. The American journal of managed care, 2009, Volume: 15, Issue:2 Suppl Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pyridines; Stents; Time Factors	2009
Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment. Expert review of cardiovascular therapy, 2009, Volume: 7, Issue:5 Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Risk	2009
Prasugrel: newest antiplatelet agent and its emerging role in management of acute coronary syndrome and percutaneous coronary intervention. Future cardiology, 2009, Volume: 5, Issue:3 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Drug Resistance; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyridines; Thiophenes; Ticlopidine	2009
A new generation of antiplatelet agents. Current opinion in cardiology, 2009, Volume: 24, Issue:4 Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyridines; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Receptors, Thrombin; Ticlopidine; von Willebrand Factor	2009
Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009, Volume: 5, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug Therapy, Combination; Drug-Eluting Stents; Exanthema; Female; Hemorrhage; Humans; Male; Metals; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Prosthesis Design; Publication Bias; Pyridines; Randomized Controlled Trials as Topic; Risk Assessment; Stents; Tetrazoles; Thrombosis; Treatment Outcome	2009
[Thienopyridines in the treatment and prevention of cardiovascular diseases. III. therapeutic application of clopidogrel as monotherapy (without acetylsalicylic acid)]. Kardiologiia, 2009, Volume: 49, Issue:12 Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Pyridines; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Ticlopidine; Ulcer	2009
Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: a meta-analysis. Journal of clinical pharmacology, 2010, Volume: 50, Issue:4 Topics: Aspirin; Cilostazol; Coronary Restenosis; Coronary Vessels; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Pyridines; Randomized Controlled Trials as Topic; Tetrazoles	2010
Combination antithrombotic therapies. Circulation, 2010, Feb-02, Volume: 121, Issue:4 Topics: Aspirin; Atherosclerosis; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Pyridines; Thrombosis; Ticlopidine	2010
Perioperative management of patients with drug-eluting stents. JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:2 Topics: Aspirin; Coronary Restenosis; Drug Therapy, Combination; Drug-Eluting Stents; Perioperative Care; Platelet Aggregation Inhibitors; Pyridines; Risk Factors	2010
Preventing serious sequelae after an acute coronary syndrome: the consequences of thrombosis versus bleeding with antiplatelet therapy. Journal of cardiovascular pharmacology, 2010, Volume: 55, Issue:6 Topics: Acute Coronary Syndrome; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Artery Bypass; Hemorrhage; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyridines; Risk Factors; Thiophenes; Thrombosis; Ticlopidine	2010
Antiplatelet therapy in percutaneous coronary intervention: recent advances in oral antiplatelet agents. Current opinion in cardiology, 2010, Volume: 25, Issue:4 Topics: Adenosine; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Therapy, Combination; Humans; Piperazines; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prasugrel Hydrochloride; Pyridines; Risk Factors; Thiophenes; Ticagrelor; Ticlopidine	2010
New insight in antiplatelet therapy monitoring in cardiovascular patients: from aspirin to thienopyridine. Cardiovascular & hematological disorders drug targets, 2010, Sep-01, Volume: 10, Issue:3 Topics: Aspirin; Cardiovascular Diseases; Humans; Platelet Aggregation Inhibitors; Pyridines	2010
Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery. The Annals of thoracic surgery, 2010, Volume: 90, Issue:3 Topics: Administration, Oral; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Artery Bypass; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyridines; Thiophenes; Thrombosis; Ticlopidine	2010
[Thienopyridines in the treatment and prevention of cardiovascular diseases. Part V. Combination of clopidogrel and acetylsalicylic acid in the treatment of stable patients with atherothrombotic cardiovascular diseases]. Kardiologiia, 2010, Volume: 50, Issue:5 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Arteriosclerosis; Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Circulation; Death, Sudden, Cardiac; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Streptokinase; Stroke; Thrombosis; Ticlopidine; Time Factors	2010
[ADP receptor blockers: new insights in the therapy and prophylaxis of ischemic heart disease]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:27 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Pyridines; Receptors, Purinergic P2; Stents; Ticlopidine	2011
Management of antiplatelet therapy inpatients at risk for coronary StentThrombosis undergoing non-cardiac surgery. Drugs, 2011, Oct-01, Volume: 71, Issue:14 Topics: Aspirin; Blood Vessel Prosthesis; Coronary Thrombosis; Drug Therapy, Combination; Humans; Inpatients; Platelet Aggregation Inhibitors; Pyridines; Risk Factors; Stents; Surgical Procedures, Operative; Time Factors	2011
A meta-analysis of randomized controlled trials appraising the efficacy and safety of cilostazol after coronary artery stent implantation. Cardiology, 2012, Volume: 122, Issue:3 Topics: Aspirin; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cilostazol; Clopidogrel; Combined Modality Therapy; Coronary Restenosis; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Stents; Tetrazoles; Ticlopidine; Treatment Outcome	2012
Systematic review with meta-analysis: the risk of gastrointestinal haemorrhage post-polypectomy in patients receiving anti-platelet, anti-coagulant and/or thienopyridine medications. Alimentary pharmacology & therapeutics, 2015, Volume: 42, Issue:8 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Blood Coagulation Disorders; Colonic Polyps; Colonoscopy; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Pyridines; Risk Factors; Warfarin	2015

Trials

29 trial(s) available for aspirin and thienopyridine

Article	Year
Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation, 2004, Sep-21, Volume: 110, Issue:12 Topics: Abciximab; Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Cohort Studies; Combined Modality Therapy; Coronary Angiography; Coronary Restenosis; Female; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Life Tables; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Pyridines; Stents; Stroke; Treatment Outcome	2004
Aspirin, warfarin and a thienopyridine for acute coronary syndromes. Cardiology, 2006, Volume: 105, Issue:2 Topics: Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Hematologic Agents; Humans; Male; Pyridines; Risk Factors; Syndrome; Ticlopidine; Ventricular Function; Warfarin	2006
Efficacy and safety of triple antiplatelet therapy with and without concomitant anticoagulation during elective percutaneous coronary intervention (the REMOVE trial). The American journal of cardiology, 2007, Oct-01, Volume: 100, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Eptifibatide; Female; Heparin; Humans; Male; Middle Aged; Peptides; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Pyridines; Ticlopidine; Treatment Outcome	2007
Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction. Journal of interventional cardiology, 2009, Volume: 22, Issue:4 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Confidence Intervals; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Immunoglobulin Fab Fragments; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Revascularization; Odds Ratio; Platelet Aggregation Inhibitors; Preoperative Care; Pyridines; Time Factors	2009
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. Lancet (London, England), 2009, Jul-04, Volume: 374, Issue:9683 Topics: Acute Coronary Syndrome; Administration, Oral; Aspirin; Chest Pain; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Morpholines; Myocardial Infarction; Proportional Hazards Models; Pyridines; Recurrence; Risk Reduction Behavior; Rivaroxaban; Safety; Statistics, Nonparametric; Stroke; Thiophenes; Treatment Outcome	2009
Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009, Volume: 5, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug Therapy, Combination; Drug-Eluting Stents; Exanthema; Female; Hemorrhage; Humans; Male; Metals; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Prosthesis Design; Publication Bias; Pyridines; Randomized Controlled Trials as Topic; Risk Assessment; Stents; Tetrazoles; Thrombosis; Treatment Outcome	2009
Reducing cardiac ischemic events in patients with ACS: prasugrel versus clopidogrel. Commentary. Postgraduate medicine, 2010, Volume: 122, Issue:1 Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Humans; Myocardial Ischemia; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyridines; Thiophenes; Ticlopidine	2010
Determinants of intracranial hemorrhage incidence in patients on oral anticoagulation followed at the Lahey clinic. Journal of thrombosis and thrombolysis, 2011, Volume: 32, Issue:3 Topics: Age Factors; Aged; Anticoagulants; Aspirin; Blood Pressure; Case-Control Studies; Databases, Factual; Female; Humans; Incidence; International Normalized Ratio; Intracranial Hemorrhages; Male; Models, Cardiovascular; Platelet Aggregation Inhibitors; Pyridines; Risk; Sex Factors; Warfarin	2011
Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZO The American journal of cardiology, 2012, Mar-15, Volume: 109, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Postoperative Period; Prospective Studies; Pyridines; Treatment Outcome	2012
Bedside monitoring to adjust antiplatelet therapy for coronary stenting. The New England journal of medicine, 2012, Nov-29, Volume: 367, Issue:22 Topics: Aged; Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Monitoring; Female; Humans; Male; Middle Aged; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Point-of-Care Systems; Prasugrel Hydrochloride; Pyridines; Retreatment; Stents; Thiophenes; Ticlopidine	2012
Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2013, Jan-22, Volume: 8, Issue:9 Topics: Aspirin; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Patient Compliance; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyridines; Surveys and Questionnaires; Treatment Outcome	2013
Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51. Journal of the American College of Cardiology, 2013, Jul-23, Volume: 62, Issue:4 Topics: Acute Coronary Syndrome; Aged; Aspirin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Morpholines; Platelet Aggregation Inhibitors; Pyridines; Rivaroxaban; Stents; Thiophenes; Thrombosis; Treatment Outcome	2013
Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial. European heart journal, 2014, Volume: 35, Issue:4 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Double-Blind Method; Embolism; Female; Humans; Kaplan-Meier Estimate; Male; Morpholines; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyridines; Rivaroxaban; Stroke; Thiophenes; Ticlopidine; Treatment Outcome; Warfarin	2014
Frequency of the use of low- versus high-dose aspirin in dual antiplatelet therapy after percutaneous coronary intervention (from the Dual Antiplatelet Therapy study). The American journal of cardiology, 2014, Apr-01, Volume: 113, Issue:7 Topics: Aspirin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Period; Pyridines; Retrospective Studies; Stents; Treatment Outcome	2014
Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy. Thrombosis and haemostasis, 2014, May-05, Volume: 111, Issue:5 Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Aspirin; Biomarkers; Blood Platelets; Cells, Cultured; Europe; Female; Follow-Up Studies; Humans; Inflammation Mediators; Lactones; Male; Middle Aged; North America; Platelet Aggregation; Pyridines; Receptor, PAR-1; Receptors, Thrombin	2014
Detecting a thienopyridine effect by platelet reactivity assessment and its implications for risk stratification. Journal of thrombosis and haemostasis : JTH, 2014, Volume: 12, Issue:4 Topics: Aged; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Platelet Activation; Point-of-Care Systems; Prasugrel Hydrochloride; Pyridines; Receptors, Purinergic P2Y12; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Thiophenes; Ticlopidine; Time Factors; Treatment Outcome	2014
Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial. Lancet (London, England), 2014, Nov-01, Volume: 384, Issue:9954 Topics: Adolescent; Adult; Aged; Aspirin; Coronary Artery Disease; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Pyridines; Treatment Outcome; Young Adult	2014
Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement. Circulation, 2015, Jan-06, Volume: 131, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Incidence; Internationality; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Pyridines; Thiophenes; Time Factors; Treatment Outcome	2015
Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial. JAMA, 2015, Mar-17, Volume: 313, Issue:11 Topics: Aged; Aspirin; Cardiovascular Diseases; Coronary Restenosis; Double-Blind Method; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Intention to Treat Analysis; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyridines; Risk; Stents	2015
Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction. Journal of the American College of Cardiology, 2015, May-26, Volume: 65, Issue:20 Topics: Aspirin; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Pyridines; Risk Assessment; Stents; Thrombosis; Time Factors	2015
Causes of late mortality with dual antiplatelet therapy after coronary stents. European heart journal, 2016, Jan-21, Volume: 37, Issue:4 Topics: Aspirin; Cause of Death; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Neoplasms; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyridines; Treatment Outcome	2016
Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents. JACC. Cardiovascular interventions, 2016, Jan-25, Volume: 9, Issue:2 Topics: Aged; Aspirin; Cardiovascular Agents; Coronary Artery Disease; Coronary Thrombosis; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Design; Pyridines; Risk Factors; Time Factors; Treatment Outcome	2016
Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study. Circulation, 2016, May-03, Volume: 133, Issue:18 Topics: Aged; Aspirin; Diabetes Mellitus; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyridines	2016
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA, 2016, Apr-26, Volume: 315, Issue:16 Topics: Age Factors; Aged; Antineoplastic Agents, Phytogenic; Aspirin; Diabetes Mellitus; Drug-Eluting Stents; Female; Hemorrhage; Humans; Ischemia; Linear Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyridines; Risk Assessment; Risk Factors; Smoking; Thrombosis; Time Factors	2016
DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction. Journal of the American College of Cardiology, 2016, May-31, Volume: 67, Issue:21 Topics: Aspirin; Decision Support Techniques; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyridines; Risk Assessment; Secondary Prevention; Stents; Thrombosis	2016
Decreased Serum Albumin Predicts Bleeding Events in Patients on Antiplatelet Therapy After Percutaneous Coronary Intervention. Circulation journal : official journal of the Japanese Circulation Society, 2017, Jun-23, Volume: 81, Issue:7 Topics: Aged; Aged, 80 and over; Aspirin; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Pyridines; Risk Factors; Serum Albumin, Human; Time Factors	2017
Vascular response to biolimus A-9 eluting stent in patients with shorter and prolonged dual antiplatelet therapy: optical coherence tomography sub-study of the NIPPON trial. Heart and vessels, 2018, Volume: 33, Issue:8 Topics: Aged; Aspirin; Coronary Artery Disease; Coronary Vessels; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyridines; Retrospective Studies; Single-Blind Method; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vascular Resistance	2018
Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial. American heart journal, 2019, Volume: 215 Topics: Aged; Aspirin; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Outcome and Process Assessment, Health Care; Platelet Aggregation Inhibitors; Proportional Hazards Models; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Risk Factors; Thrombolytic Therapy	2019
Interruption of Dual Antiplatelet Therapy Within Six Months After Coronary Stents (from the Dual Antiplatelet Therapy Study). The American journal of cardiology, 2019, 12-15, Volume: 124, Issue:12 Topics: Aged; Aspirin; Combined Modality Therapy; Coronary Angiography; Coronary Artery Disease; Dual Anti-Platelet Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Predictive Value of Tests; Pyridines; Risk Assessment; Stents; Survival Rate; Time Factors; Treatment Outcome; United States; Withholding Treatment	2019

Other Studies

51 other study(ies) available for aspirin and thienopyridine

Article	Year
Going with the flow of anticoagulant therapy. Nursing, 2003, Volume: 33, Issue:3 Topics: Anticoagulants; Aspirin; Dipyridamole; Heparin; Humans; Patient Education as Topic; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Prothrombin; Pulmonary Embolism; Pyridines; Thoracic Surgery; Thrombophilia; Warfarin	2003
Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. Journal of the American College of Cardiology, 2003, Jul-16, Volume: 42, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Blood Transfusion; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Minnesota; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Pyridines; Retrospective Studies; Stents; Surgical Procedures, Operative; Time Factors; Treatment Outcome; Warfarin	2003
Underuse of aspirin in type 2 diabetes mellitus: prevalence and correlates of therapy in rural Canada. Clinical therapeutics, 2004, Volume: 26, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Alberta; Aspirin; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Drug Utilization; Female; Humans; Male; Middle Aged; Patient Compliance; Platelet Aggregation Inhibitors; Pyridines; Rural Population	2004
Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication. Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Combined Modality Therapy; Coronary Restenosis; Female; Fibrinolysis; Fibrinolytic Agents; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Pyridines; Retrospective Studies; Stents; Ticlopidine; Tissue Plasminogen Activator	2005
Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study. Italian heart journal : official journal of the Italian Federation of Cardiology, 2005, Volume: 6, Issue:2 Topics: Acetylcysteine; Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Utilization Review; Female; Health Care Surveys; Heparin; Humans; Italy; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Pyridines; Registries; Ticlopidine	2005
Early discharge using five french guiding catheter for transfemural coronary stenting: a feasibility and safety study (EDU 5Fr study). The American journal of cardiology, 2005, Sep-15, Volume: 96, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Feasibility Studies; Female; Heparin; Humans; Length of Stay; Male; Middle Aged; Patient Discharge; Platelet Aggregation Inhibitors; Prospective Studies; Pyridines; Stents; Time Factors; Treatment Outcome	2005
Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2006, Volume: 68, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Blood Coagulation Tests; Coronary Angiography; Coronary Disease; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography, Doppler; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Pyridines; Research Design; Retrospective Studies; Survival Analysis; Warfarin	2006
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, Circulation, 2007, Feb-13, Volume: 115, Issue:6 Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Thrombosis; Drug Delivery Systems; Drug Therapy, Combination; Elective Surgical Procedures; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Period; Practice Guidelines as Topic; Pyridines; Stents; Time Factors	2007
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, Journal of the American College of Cardiology, 2007, Feb-13, Volume: 49, Issue:6 Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Thrombosis; Drug Delivery Systems; Drug Therapy, Combination; Elective Surgical Procedures; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Period; Practice Guidelines as Topic; Pyridines; Stents; Time Factors	2007
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, Journal of the American Dental Association (1939), 2007, Volume: 138, Issue:5 Topics: Aspirin; Coronary Disease; Coronary Thrombosis; Drug Administration Schedule; Education, Professional; Elective Surgical Procedures; Humans; Myocardial Infarction; Patient Education as Topic; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Pyridines; Risk Factors; Stents; Time Factors	2007
Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation, 2007, Aug-14, Volume: 116, Issue:7 Topics: Aged; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Pyridines; Sirolimus; Stents; Thrombosis; Treatment Outcome	2007
Drug-eluting stents: dual antiplatelet therapy for every survivor? Circulation, 2007, Aug-14, Volume: 116, Issue:7 Topics: Algorithms; Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Incidence; Paclitaxel; Platelet Aggregation Inhibitors; Pyridines; Sirolimus; Stents; Survivors; Thrombosis; Ticlopidine	2007
Synthesis and biological evaluation of thieno[2,3-d]pyrimidine derivatives for anti-inflammatory, analgesic and ulcerogenic activity. Acta pharmaceutica (Zagreb, Croatia), 2007, Volume: 57, Issue:4 Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Aspirin; Carrageenan; Disease Models, Animal; Female; Indomethacin; Inflammation; Male; Mice; Molecular Structure; Pain; Pain Measurement; Pain Threshold; Pyridines; Rats; Stomach Ulcer; Structure-Activity Relationship	2007
[Medical treatment of patients with clinical peripheral arterial disease at hospital discharge: compliance with the French guidelines and changing practices (COPART I registry)]. Journal des maladies vasculaires, 2008, Volume: 33, Issue:1 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensins; Aspirin; Cohort Studies; Drug Prescriptions; Female; France; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Patient Discharge; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pyridines; Registries; Renin; Renin-Angiotensin System; Retrospective Studies	2008
"Triple therapy" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents. Journal of the American College of Cardiology, 2008, Feb-26, Volume: 51, Issue:8 Topics: Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Humans; Pyridines; Risk Factors; Stents; Thromboembolism; Warfarin	2008
[Prescription, monitoring of antithrombotic treatment: 1--antiplatelet agents]. La Revue du praticien, 2007, Nov-30, Volume: 57, Issue:18 Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Contraindications; Cyclooxygenase Inhibitors; Drug Combinations; Drug Monitoring; Drug Prescriptions; Drug Resistance; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Surgical Procedures, Operative; Thrombolytic Therapy; Venous Thrombosis	2007
Thrombocytopenia in patients treated with heparin, combination antiplatelet therapy, and intra-aortic balloon pump counterpulsation. Journal of interventional cardiology, 2008, Volume: 21, Issue:4 Topics: Anticoagulants; Aspirin; Cohort Studies; Drug Therapy, Combination; Female; Heparin; Humans; Incidence; Intra-Aortic Balloon Pumping; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Retrospective Studies; Risk Factors; Thrombocytopenia	2008
Benefits and limitations of current antiplatelet therapies. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Jul-01, Volume: 65, Issue:13 Suppl 5 Topics: Acute Coronary Syndrome; Aspirin; Clinical Protocols; Drug Therapy; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Pyridines; Risk Factors; Stents	2008
Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 2008, Volume: 133, Issue:6 Suppl Topics: Aspirin; Cyclooxygenase Inhibitors; Evidence-Based Medicine; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines	2008
Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding. Circulation, 2008, Nov-18, Volume: 118, Issue:21 Topics: Acute Disease; Adult; Aged; Aspirin; Female; Follow-Up Studies; Hematocrit; Hemorrhage; Hospitals; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyridines; Registries; Regression Analysis	2008
Incidence of bleeding and compliance on prolonged dual antiplatelet therapy (aspirin + thienopyridine) following drug-eluting stent implantation. The American journal of cardiology, 2008, Dec-01, Volume: 102, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Confidence Intervals; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Immunosuppressive Agents; Incidence; Italy; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Platelet Aggregation Inhibitors; Prospective Studies; Pyridines; Risk Factors; Sirolimus; Time Factors	2008
Status of drug-eluting coronary stents. Medicine and health, Rhode Island, 2008, Volume: 91, Issue:10 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Consensus; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Paclitaxel; Platelet Aggregation Inhibitors; Pyridines; Sirolimus	2008
Effects of gastric medicines on gastroduodenal injury in patients with stable angina during antiplatelet therapy. Journal of cardiology, 2009, Volume: 54, Issue:1 Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Female; Follow-Up Studies; Gastric Mucosa; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Male; Peptic Ulcer; Platelet Aggregation Inhibitors; Propensity Score; Proton Pump Inhibitors; Pyridines; Stents	2009
Test before you stop. Archives of surgery (Chicago, Ill. : 1960), 2009, Volume: 144, Issue:8 Topics: Adenosine; Algorithms; Aspirin; Clinical Trials as Topic; Clopidogrel; Humans; Perioperative Care; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Pyridines; Risk Factors; Thiophenes; Ticagrelor; Ticlopidine	2009
Balancing thromboembolism and bleeding risks: insights from anticoagulation for prosthetic heart valves. Chest, 2009, Volume: 136, Issue:6 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Dose-Response Relationship, Drug; Heart Valve Prosthesis; Hemorrhage; Humans; Mitral Valve; Platelet Aggregation Inhibitors; Pyridines; Risk Factors; Thromboembolism	2009
Impact of high-responsiveness to dual antiplatelet therapy on bleeding complications in patients receiving drug-eluting stents. Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:4 Topics: Aged; Angioplasty, Balloon, Laser-Assisted; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Pyridines; Retrospective Studies; Risk Factors; Ticlopidine; Treatment Outcome	2010
Impact of anticoagulant therapy with dual antiplatelet therapy on prognosis after treatment with drug-eluting coronary stents. Journal of cardiology, 2010, Volume: 55, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Cardiovascular Diseases; Coronary Disease; Drug-Eluting Stents; Female; Hemorrhage; Humans; Kidney Diseases; Male; Platelet Aggregation Inhibitors; Prognosis; Pyridines; Retrospective Studies; Ventricular Dysfunction; Warfarin	2010
[Does dual antiplatelet therapy always require gastroprotection? Tailored medical therapy should prevail over the generalized prescription of proton pump inhibitors in patients on dual antiplatelet therapy]. Giornale italiano di cardiologia (2006), 2010, Volume: 11, Issue:6 Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Myocardial Infarction; Myocardial Revascularization; Odds Ratio; Peptic Ulcer; Platelet Aggregation Inhibitors; Prognosis; Proton Pump Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Ticlopidine; Time Factors	2010
Morbidity associated with three different antiplatelet regimens in patients undergoing implantation of cardiac rhythm management devices. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2011, Volume: 13, Issue:3 Topics: Aged; Aged, 80 and over; Anticoagulants; Arrhythmias, Cardiac; Aspirin; Cardiac Resynchronization Therapy Devices; Defibrillators, Implantable; Drug Therapy, Combination; Enoxaparin; Female; Hematoma; Humans; Length of Stay; Male; Middle Aged; Multivariate Analysis; Pacemaker, Artificial; Platelet Aggregation Inhibitors; Prospective Studies; Pyridines; Reoperation; Retrospective Studies; Risk Factors	2011
Combination of low-dose aspirin and thienopyridine exacerbates small bowel injury. Scandinavian journal of gastroenterology, 2011, Volume: 46, Issue:3 Topics: Aged; Aged, 80 and over; Aspirin; Capsule Endoscopy; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Intestinal Mucosa; Intestine, Small; Male; Middle Aged; Pyridines; Retrospective Studies; Ticlopidine; Ulcer; Warfarin	2011
Rivaroxaban (Xarelto) for acute coronary syndrome. The Medical letter on drugs and therapeutics, 2011, Dec-12, Volume: 53, Issue:1379-1380 Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Approval; Drug Therapy, Combination; Factor Xa Inhibitors; Humans; Morpholines; Pyridines; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; United States; United States Food and Drug Administration	2011
Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2. Circulation. Cardiovascular interventions, 2012, Volume: 5, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Chi-Square Distribution; Clopidogrel; Cohort Studies; Coronary Artery Disease; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Japan; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Pyridines; Registries; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2012
Consideration of dual anti-platelet therapy duration after drug-eluting stent implantation in a Japanese population: a five-year follow-up after sirolimus-eluting stent implantation. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:7 Topics: Aged; Asian People; Aspirin; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Population Surveillance; Prospective Studies; Pyridines; Retrospective Studies; Sirolimus; Time Factors; Treatment Outcome	2013
The quality of antiplatelet and anticoagulant medication administration among ST-segment elevation myocardial infarction patients transferred for primary percutaneous coronary intervention. American heart journal, 2014, Volume: 167, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Early Medical Intervention; Female; Guideline Adherence; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Male; Middle Aged; Myocardial Infarction; Patient Transfer; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Pyridines; Recombinant Proteins; Retrospective Studies; Ticlopidine; Time-to-Treatment	2014
Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation. Coronary artery disease, 2015, Volume: 26, Issue:5 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Chi-Square Distribution; Coronary Artery Disease; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Propensity Score; Proportional Hazards Models; Pyridines; Republic of Korea; Retrospective Studies; Risk Factors; Stents; Time Factors; Treatment Outcome; Warfarin	2015
Assessing the optimal strategy for dual antiplatelet therapy. Expert review of cardiovascular therapy, 2015, Volume: 13, Issue:10 Topics: Aspirin; Coronary Artery Disease; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Pyridines; Risk; Stents; Thrombosis	2015
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. The American journal of medicine, 2016, Volume: 129, Issue:6 Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Comorbidity; Coronary Artery Disease; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hospitalization; Humans; Male; Markov Chains; Monte Carlo Method; Myocardial Infarction; Outcome and Process Assessment, Health Care; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Pyridines; Registries; Stroke; Ticlopidine; Warfarin	2016
What is the appropriate duration of dual antiplatelet therapy? JAAPA : official journal of the American Academy of Physician Assistants, 2016, Volume: 29, Issue:2 Topics: Aspirin; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Period; Pyridines; Risk Assessment; Risk Factors; Thrombosis; Time Factors	2016
Impact of preoperative dual antiplatelet therapy on bleeding complications in patients with acute coronary syndromes who undergo urgent coronary artery bypass grafting. Journal of cardiology, 2017, Volume: 69, Issue:1 Topics: Acute Coronary Syndrome; Aged; Aspirin; Blood Transfusion; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Emergencies; Female; Humans; Japan; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Preoperative Care; Pyridines; Retrospective Studies; Ticlopidine; Time Factors; Treatment Outcome	2017
[Antiplatelet medicine]. Nihon rinsho. Japanese journal of clinical medicine, 2016, Jun-20, Volume: 74 Suppl 4 Pt 1 Topics: Aspirin; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Pyridines	2016
Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy. American heart journal, 2016, Volume: 182 Topics: Aged; Aspirin; Comorbidity; Coronary Artery Disease; Diabetes Mellitus; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Long Term Adverse Effects; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyridines; Registries; Risk Assessment	2016
Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study. JAMA cardiology, 2017, 05-01, Volume: 2, Issue:5 Topics: Aged; Aspirin; Brain Ischemia; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Mortality; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Care; Pyridines; Stents; Stroke	2017
Impact of Dual Antiplatelet Therapy Beyond 1 Year on Clinical Outcomes of Patients With Stent Fracture or Peri-Stent Contrast Staining After Sirolimus-Eluting Stent Implantation. Circulation journal : official journal of the Japanese Circulation Society, 2017, 12-25, Volume: 82, Issue:1 Topics: Aged; Aspirin; Death; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prosthesis Implantation; Pyridines; Retrospective Studies; Sirolimus; Staining and Labeling; Thrombosis; Time Factors; Treatment Outcome	2017
Safety of Antiplatelet Agents: Analysis of 'Real-World' Data from the Italian National Pharmacovigilance Network. Clinical drug investigation, 2017, Volume: 37, Issue:11 Topics: Adenosine; Adult; Aged; Aged, 80 and over; Aspirin; Female; Hemorrhage; Humans; Italy; Male; Middle Aged; Pharmacovigilance; Platelet Aggregation Inhibitors; Pyridines; Ticagrelor	2017
Lower gastrointestinal bleeding in patients with coronary artery disease on antithrombotics and subsequent mortality risk. Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:6 Topics: Aged; Anticoagulants; Aspirin; Cohort Studies; Coronary Artery Disease; Drug Therapy; Female; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Multivariate Analysis; Pyridines; Retrospective Studies; Risk; Risk Factors; Time Factors	2018
Continuous Use of Thienopyridine May Be as Safe as Low-Dose Aspirin in Endoscopic Resection of Gastric Tumors. Gut and liver, 2018, 07-15, Volume: 12, Issue:4 Topics: Aged; Aged, 80 and over; Aspirin; Drug Administration Schedule; Endoscopic Mucosal Resection; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Pyridines; Retrospective Studies; Risk Factors; Stomach Neoplasms; Time Factors; Treatment Outcome	2018
On-treatment platelet reactivity in peripheral and coronary blood in patients undergoing primary PCI for ST-segment elevation myocardial infarction (STEMI). Scandinavian journal of clinical and laboratory investigation, 2018, Volume: 78, Issue:4 Topics: Adenosine Diphosphate; Arachidonic Acid; Aspirin; Blood Platelets; Coronary Vessels; Demography; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; ST Elevation Myocardial Infarction	2018
Risk factors for upper gastrointestinal bleeding among aspirin users: An old issue with new findings from a population-based cohort study. Journal of the Formosan Medical Association = Taiwan yi zhi, 2019, Volume: 118, Issue:5 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Comorbidity; Cyclooxygenase 2 Inhibitors; Databases, Factual; Female; Gastrointestinal Hemorrhage; Helicobacter Infections; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Pyridines; Risk Factors; Steroids; Taiwan	2019
The Effects of Direct Oral Anticoagulants, Warfarin, Aspirin and Thienopyridine on the Performance of Immunochemical, Faecal, Occult Blood Tests. Digestion, 2019, Volume: 100, Issue:2 Topics: Adenoma; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Case-Control Studies; Colonoscopy; Colorectal Neoplasms; False Positive Reactions; Feces; Female; Humans; Japan; Male; Mass Screening; Middle Aged; Occult Blood; Predictive Value of Tests; Prospective Studies; Pyridines; Retrospective Studies; Warfarin	2019
Endoscopic biliary sphincterotomy on thienopyridine therapy compared to low dose aspirin alone has similar outcomes. Minerva gastroenterologica e dietologica, 2019, Volume: 65, Issue:3 Topics: Aged; Aspirin; Humans; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Pyridines; Retrospective Studies; Risk Factors; Sphincterotomy, Endoscopic; Treatment Outcome	2019
Management, hospital outcome and revascularization trends in non-ST elevation myocardial infarction with high GRACE risk score. JPMA. The Journal of the Pakistan Medical Association, 2019, Volume: 69, Issue:10 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Cross-Sectional Studies; Disease Management; Female; Guideline Adherence; Heparin; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Revascularization; Non-ST Elevated Myocardial Infarction; Pakistan; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pyridines; Retrospective Studies	2019